Utz Brands Stock Hits 52-Week Low at $13.36 Amid Market Challenges
In a challenging market environment, Utz Brands Inc. (NYSE: UTZ) stock has touched a 52-week low, dipping to $13.36. The ...
Healio10m
Linsitinib for thyroid eye disease shows proptosis reduction, safety in phase 2b/3 trial
Linsitinib, an oral small molecule under development for the treatment of thyroid eye disease, demonstrated proptosis reduction and safety in the phase 2b/3 LIDS trial, according to a press release ...
Target’s Holiday Sales Were Strong. It’s a Relief for Investors.
While Target reported strong holiday sales on Thursday, it wasn’t enough to give the stock a boost.The retail chain said ...